Ontology highlight
ABSTRACT: Objective
This study examined the role of lithium in the maintenance treatment of pediatric patients with bipolar I disorder (BP-I).Method
Participants aged 7 to 17 years who presented with a manic or mixed episode received 24 weeks of lithium treatment in one of two multiphase studies, the Collaborative Lithium Trials (CoLT 1 and CoLT 2). Responders were randomized to continue lithium or to be cross-titrated to placebo for up to 28 weeks. The primary outcome measure was relative risk of study discontinuation for any reason.Results
A Cox regression analysis found that those who continued treatment with lithium (n = 17) had a lower hazard ratio compared to those who received placebo (n = 14) (p = .015)]. The vast majority of discontinuations were due to mood symptom
SUBMITTER: Findling RL
PROVIDER: S-EPMC6414078 | biostudies-literature | 2019 Feb
REPOSITORIES: biostudies-literature